Patents by Inventor Gerry Nicolaes

Gerry Nicolaes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of CD40-TRAF6 interaction
    Patent number: 9750717
    Abstract: The present invention relates to compounds acting as selective inhibitors of CD40-TRAF6 interaction, their use as medicaments and their use in the treatment of (chronic) inflammatory diseases. The present invention also relates to pharmaceutical compositions comprising these compounds.
    Type: Grant
    Filed: February 9, 2016
    Date of Patent: September 5, 2017
    Assignees: LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN, MAASTRICHT UNIVERSITY
    Inventors: Esther Lutgens, Christian Weber, Gerry Nicolaes
  • Inhibitors of CD40-TRAF6 Interaction
    Publication number: 20160228408
    Abstract: The present invention relates to compounds acting as selective inhibitors of CD40-TRAF6 interaction, their use as medicaments and their use in the treatment of (chronic) inflammatory diseases. The present invention also relates to pharmaceutical compositions comprising these compounds.
    Type: Application
    Filed: February 9, 2016
    Publication date: August 11, 2016
    Inventors: Esther LUTGENS, Christian WEBER, Gerry NICOLAES
  • Inhibitors of CD40-TRAF6 interaction
    Patent number: 9408829
    Abstract: The present invention relates to compounds acting as selective inhibitors of CD40-TRAF6 interaction, their use as medicaments and their use in the treatment of (chronic) inflammatory diseases. The present invention also relates to pharmaceutical compositions comprising these compounds.
    Type: Grant
    Filed: August 27, 2013
    Date of Patent: August 9, 2016
    Assignees: LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN, MAASTRICHT UNIVERSITY, ACADEMISCH ZIEKENHUIS MAASTRICHT
    Inventors: Esther Lutgens, Christian Weber, Gerry Nicolaes
  • Inhibitors of CD40-TRAF6 Interaction
    Publication number: 20150190370
    Abstract: The present invention relates to compounds acting as selective inhibitors of CD40-TRAF6 interaction, their use as medicaments and their use in the treatment of (chronic) inflammatory diseases. The present invention also relates to pharmaceutical compositions comprising these compounds.
    Type: Application
    Filed: August 27, 2013
    Publication date: July 9, 2015
    Inventors: Esther Lutgens, Christian Weber, Gerry Nicolaes